Willkommen bei Valicare!
-
SMEPAC-Test
Sie verarbeiten hochwirksame Substanzen und wollen sicher gehen, dass Ihre Umwelt und Ihr Produkt geschützt ist? Mit dem SMEPAC-Test prüfen wir die Dichtigkeit Ihres Containment-Systems. Lesen Sie dazu den Newsletter unserer Experten.
Mehr erfahren -
GMP für ATMPs
Sie sind noch in der Entwicklungsphase Ihres ATMPs denken aber bereits an dessen Herstellung? Welche Schritte müssen Sie zuerst planen und welche regulatorischen Anforderungen erfüllen? Fragen Sie unsere Experten.
Mehr erfahren
Treffen Sie Valicare Experten bei den folgenden Veranstaltungen
Nachrichten aus aller Welt
Unser internationaler Pressespiegel enthält eine Auswahl von Nachrichten und aktuellen Artikeln über Arzneimittel für neuartige Therapien (ATMPs), chimäre Antigenrezeptor-T-Zelltherapie (CAR), tumorinfiltrierende Lymphozyten (TILs) und biotechnologisch hergestellte Gewebeprodukte (TEPs).
FDA Approves First Topical Gene Therapy for Treatment of Wounds in Patients with Dystrophic Epidermolysis Bullosa
19.05.2023 | FDAFor Immediate Release: May 19, 2023 ...
A Guide to Mesenchymal Stem Cell (MSC) Markers
19.05.2023 | BiocompareMesenchymal stem cells are non-hematopoietic multipotent precursor cells that can differentiate into a variety of cell types, including ...
“Untargeting” autoantibodies using genome editing, a proof-of-concept study
19.05.2023 | Science Direct... https://doi.org/10.1016/j.clim.2023.109343 ...
Imugene receives FDA approval to start human trial of CAR-T cell therapy for solid tumours
19.05.2023 | Small CapsCancer immunotherapy house Imugene (ASX: IMU) has received US Food and Drug Administration (FDA) approval to start a human trial targeting ...
Rescued from the rubbish bin: How the thymus could stop organ transplant rejection
18.05.2023 | BC Children's Hospital Research Institute
Polymeric nanoparticles containing babassu oil: A proposed drug delivery system for controlled release of hydrophilic compounds
18.05.2023 | Science Direct... https://doi.org/10.1016/j.chemphyslip.2023.105304 ...
Around the Helix: Cell and Gene Therapy Company Updates – May 17, 2023
17.05.2023 | CGTLiveCatch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.
EMA Publishes Annual Report for 2022
17.05.2023 | Pharmaceutical TechnologyThe report outlines highlights from the agency’s medicines evaluations and milestones for 2022.
Spinnenseide für Gewebe und Implantat
17.05.2023 | medizin & technik
Evolving Tools and Perspectives for the Development of Cell and Gene Therapies
16.05.2023 | Applied Clinical TrialsThis year marks the first time multiple gene therapies for the same non-oncology rare disease may be market authorized in the United States ...
FDA Awards FTD of IMPT-314 for B-Cell Mediated Malignancies
16.05.2023 | Targeted OncologyThe fast track designation to IMPT-314 is for the treatment of multiple types of B-cell lymphoma in patients who previously received 2 or ...
ReviewViral Vectors, Exosomes, and Vexosomes: Potential armamentarium for delivering CRISPR/Cas to cancer cells
16.05.2023 | Science Direct... https://doi.org/10.1016/j.bcp.2023.115555 ...
Advanced flexible materials made from nanocellulose
16.05.2023 | NanowerkMay 16, 2023 Advanced flexible materials made from nanocellulose ( Nanowerk Spotlight ) Nanocellulose, a specialized type of cellulose ...
Researchers map RNA to inform selection of stem cells for therapeutic applications
12.05.2023 | The Science Advisory BoardBy Nick Paul Taylor, The Science Advisory Board contributing writer ...
What is the Best Lymphoma Treatment After CAR T Therapy Fails?
12.05.2023 | Cancer Health... iStock/Catalin Rusnac CU Cancer Center member Ajay Major published research showing that checkpoint inhibitor therapies are not ...
Valicare – kompetent, zuverlässig & effizient
Sie haben wenig Zeit und möchten trotzdem wissen, welche Dienstleistungen die Valicare GmbH anbietet?